EUVIMEDEUVIMED entdecken
Crossref

Rasch‐Built Overall Disability Scale for IgM ‐Associated Polyneuropathy With and Without Anti‐ MAG Antibodies: IgM ‐ RODS

Tatiana Hamadeh, Johannes P M van de Mortel, Janneke G J Hoeijmakers, David R Cornblath, Alexander F J E Vrancken, Catharina G Faber, Nicolette C Notermans, Perry T C van Doormaal iD, Ingemar S J Merkies, IMAGiNe Consortium

Journal of the Peripheral Nervous System · 2025-09 · 30 (3)

DOI: 10.1111/jns.70059 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Peripheral Nervous System, online erschienen am 23.09.2025. Verfasst von Tatiana Hamadeh und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Maastricht University Medical Center+, Mental Health and Neuroscience Research Institute, Maastricht, the Netherlands. Hauptthemen laut MEDLINE: Polyneuropathies, Immunoglobulin M, Disability Evaluation, Myelin-Associated Glycoprotein. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 52 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aim IgM monoclonal gammopathy‐associated polyneuropathy with(out) anti‐myelin associated glycoprotein (±anti‐MAG) is a rare immune‐mediated disease that may cause severe limitations in daily activities and quality of life. The absence of a systematic comparison between patients with/without anti‐MAG IgM polyneuropathy, no disease‐specific functional metric, and lack of international consensus regarding assessment and treatment of these patients are factors obstructing future clinical trials. Therefore, it was decided to develop an interval Rasch‐built activity/participation scale specifically for IgM polyneuropathy ±anti‐MAG (IgM‐RODS) and examine its clinimetric properties.

Methods

A pre‐phase IgM‐RODS questionnaire containing 146 activity/participation items, based on the WHO International Classification of Functioning, Disability and Health, was completed by participants (≥ 18 years) of the IMAGiNe observational registry that fulfilled international criteria for IgM‐polyneuropathy ±anti‐MAG. Data was subjected to Rasch analyses, and reliability/validity studies were performed as well.

Results

The pre‐RODS data of 259 subjects (originating from 8 different countries) underwent quality assessment, and 244 remaining records were submitted to the Rasch model, evidencing the model's expectations. Based on requirements like exceeding fit residuals, misfit statistics, item bias, local dependency, and less face validity, we systematically removed items until the final 36‐item IgM‐RODS fulfilled all Rasch requirements and showed acceptable test–retest reliability, cross‐cultural, construct and discriminant validity, and unidimensionality. Compared to the Inflammatory‐RODS, the IgM‐RODS showed lower standard errors across the metric, indicating greater sensitivity.

Interpretation

The 36‐item IgM‐RODS is a disease‐specific interval measure suitable for detecting functional deficits in patients with IgM‐polyneuropathy ±anti‐MAG. Future studies are needed to determine its responsiveness.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PolyneuropathiesImmunoglobulin MDisability EvaluationMyelin-Associated GlycoproteinAutoantibodiesParaproteinemiasHumansMaleFemaleMiddle AgedAgedReproducibility of ResultsAdultAged, 80 and overPsychometricsSurveys and QuestionnairesSeverity of Illness Index

Stichwörter der Autor:innen

IgM RODSIgM polyneuropathyfunction Rasch‐built metric

Substanzen

Immunoglobulin MMyelin-Associated GlycoproteinAutoantibodies

Autor:innen und Institutionen

  • Department of Neurology, Maastricht University Medical Center+, Mental Health and Neuroscience Research Institute, Maastricht, the Netherlands.
  • Department of Neurology, Brain Center Rudolph Magnus, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Department of Neurology, Johns Hopkins University, Baltimore, Maryland, USA.
  • Department of Neurology, Tergooi Medical Center, Hilversum, the Netherlands.
  • Department of Neurology, Curacao Medical Center, Curaçao.

ORCID-Profile: Perry T C van Doormaal

Zitieren

APA

Hamadeh, T., van de Mortel, J. P. M., Hoeijmakers, J. G. J., Cornblath, D. R., Vrancken, A. F. J. E., Faber, C. G., Notermans, N. C., van Doormaal, P. T. C., Merkies, I. S. J., & IMAGiNe Consortium (2025). Rasch‐Built Overall Disability Scale for IgM ‐Associated Polyneuropathy With and Without Anti‐ MAG Antibodies: IgM ‐ RODS. Journal of the Peripheral Nervous System, 30(3). https://doi.org/10.1111/jns.70059

Vancouver

Hamadeh T, van de Mortel JPM, Hoeijmakers JGJ, Cornblath DR, Vrancken AFJE, Faber CG, et al. Rasch‐Built Overall Disability Scale for IgM ‐Associated Polyneuropathy With and Without Anti‐ MAG Antibodies: IgM ‐ RODS. Journal of the Peripheral Nervous System. 2025;30(3). doi:10.1111/jns.70059

BibTeX
@article{Hamadeh2025,
  author = {Hamadeh, Tatiana and van de Mortel, Johannes P M and Hoeijmakers, Janneke G J and Cornblath, David R and Vrancken, Alexander F J E and Faber, Catharina G and Notermans, Nicolette C and van Doormaal, Perry T C and Merkies, Ingemar S J and IMAGiNe Consortium, IMAGiNe Consortium},
  title = {Rasch‐Built Overall Disability Scale for IgM ‐Associated Polyneuropathy With and Without Anti‐ MAG Antibodies: IgM ‐ RODS},
  journal = {Journal of the Peripheral Nervous System},
  year = {2025},
  volume = {30},
  number = {3},
  doi = {10.1111/jns.70059}
}
Kostenlos starten →